Skip to main content
Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · IEX Real-Time Price · USD
2.350
-0.080 (-3.29%)
May 17, 2024, 11:45 AM EDT - Market closed

Barinthus Biotherapeutics Revenue

Barinthus Biotherapeutics had revenue of $334.00K in the twelve months ending March 31, 2024, down -98.89% year-over-year. In the year 2023, Barinthus Biotherapeutics had annual revenue of $802.00K, a decrease of -98.21%.

Revenue (ttm)
$334.00K
Revenue Growth
-98.89%
P/S Ratio
274.07
Revenue / Employee
$2,569
Employees
130
Market Cap
91.54M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023802.00K-43.90M-98.21%
Dec 31, 202244.70M44.44M16,580.22%
Dec 31, 2021268.00K-4.55M-94.44%
Dec 31, 20204.82M-2.02M-29.57%
Dec 31, 20196.85M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xtant Medical Holdings 101.23M
Eton Pharmaceuticals 35.30M
BrainsWay 34.26M
Elutia 28.99M
Oramed Pharmaceuticals 674.00K
Revenue Rankings

BRNS News

More News